Trademark: 78888833
Word
HORIZANT
Status
Dead
Status Code
606
Status Date
Monday, April 19, 2010
Serial Number
78888833
Mark Type
4000
Filing Date
Monday, May 22, 2006
Published for Opposition
Tuesday, December 26, 2006
Abandoned Date
Monday, April 19, 2010

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; and for vaccines

Trademark Events
May 13, 2010
Teas Change Of Correspondence Received
Apr 19, 2010
Abandonment Notice Mailed - No Use Statement Filed
Apr 19, 2010
Abandonment - No Use Statement Filed
Oct 24, 2009
Teas Change Of Correspondence Received
Aug 28, 2009
Extension 5 Granted
Aug 27, 2009
Extension 5 Filed
Aug 27, 2009
Teas Extension Received
Jul 6, 2009
Attorney Revoked And/Or Appointed
Jul 6, 2009
Teas Revoke/Appoint Attorney Received
Feb 25, 2009
Extension 4 Granted
Feb 25, 2009
Extension 4 Filed
Feb 25, 2009
Teas Extension Received
Aug 6, 2008
Extension 3 Granted
Jul 25, 2008
Extension 3 Filed
Aug 6, 2008
Case Assigned To Intent To Use Paralegal
Jul 25, 2008
Teas Extension Received
Feb 5, 2008
Extension 2 Granted
Feb 5, 2008
Extension 2 Filed
Feb 5, 2008
Teas Extension Received
Jul 31, 2007
Extension 1 Granted
Jul 31, 2007
Extension 1 Filed
Jul 31, 2007
Teas Extension Received
Mar 20, 2007
Noa Mailed - Sou Required From Applicant
Dec 26, 2006
Published For Opposition
Dec 6, 2006
Notice Of Publication
Nov 2, 2006
Law Office Publication Review Completed
Nov 2, 2006
Assigned To Lie
Oct 24, 2006
Approved For Pub - Principal Register
Oct 24, 2006
Assigned To Examiner
May 26, 2006
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24